Rosenholm Pharma & Management Consulting ABActive

559419-0885Limited company (AB)Registered 2023LIDINGÖ

Key figures

573 000 kr−65,6%
Revenue 2025
−4,7%
Average annual change 2023–2025
0500 k1 m1,5 m2 m202320242025

Key figures

2025
Balance structure
Current assetsFixed assetsLiabilitiesEquity
0500 k1 m1,5 m202320242025
Summary of annual reports2023–2025
202320242025
Balance sheet — assets
Total current assets548 6931 216 731953 224
Total non-current assets———
Total assets548 6931 216 731953 224
Balance sheet — liabilities and equity
Current liabilities199 780371 345169 296
Non-current liabilities———
Total liabilities199 779371 345169 296
Share capital25 00025 00025 000
Retained earnings of previous periods———
Profit for the year (equity)323 914496 472142 543
Total equity348 914845 386783 928
Income statement
Sales revenue631 0001 666 000573 000
Operating profit410 702625 893180 576
Profit before income tax411 019627 797179 752
Profit for the reporting year323 914496 472142 543
Labour costs157 085928 998320 626
Depreciation of non-current assets———
Other indicators
Employees111
Proposed dividend———

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Similar companies

Summary: Rosenholm Pharma & Management Consulting AB

Overview

Rosenholm Pharma & Management Consulting AB (org. no. 559419-0885) is a limited company (AB). The company was registered in 2023 and has existed for 3 years. Registered seat: Lidingö. Industry according to Statistics Sweden: business and other management consultancy activities (SNI 70200).

Economy

Net sales in financial year 2025 were 573 000 kr, down 65,6 % on the previous year (1 666 000 kr). From 2023 to 2025, net sales declined by an average of 4,7 % per year. Net profit for 2025 was 142 543 kr (24,9 % of net sales). The company was profitable in all 3 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 573 000 kr. At the end of financial year 2025, total assets were 953 224 kr and equity 783 928 kr (equity ratio 82,2 %).

Sources and freshness

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-10-26. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.